MSD BELGIUM
The computed 12-month bankruptcy probability of MSD BELGIUM is 0.7% (low). The 2023 annual accounts show equity of €53.38M and a net result of €15.50M. The company has been active since 1969 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €53.38M |
| Net result | €15.50M |
| Staff (FTE) | 151 |
| Active | 56 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Fiscal year | 2023 |
|---|---|
| Deposit | volledig |
| Revenue | €567.48M |
| EBITDA | €19.99M |
| Net profit | €15.50M |
| Cash flow | €15.63M |
| Staff costs | €25.23M |
| Income taxes | €5.44M |
| Dividends | €0 |
| Total assets | €156.13M |
| Equity | €53.38M |
| Debt | €102.75M |
| of which ≤ 1y | €102.75M |
| of which > 1y | - |
| Working capital | €52.98M |
| Employees (FTE) | 151.0 |
| 2023 | |
|---|---|
| Current ratio | 1.52 |
| Quick ratio | 1.52 |
| Working capital ratio | 33.9% |
| Solvency | 34.2% |
| Debt / equity | 1.92 |
| Long-term debt ratio | - |
| Interest coverage | 202.63 |
| Gross margin | 56.3% |
| Net margin | 2.7% |
| ROA | 9.9% |
| ROE | 29.0% |
| EBITDA margin | 3.5% |
| Days sales outstanding | 71d |
| Days payable outstanding | 71d |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €156.13M |
| Fixed assets | 21/28 | €401k |
| Intangible fixed assets | 21 | €396k |
| Tangible fixed assets | 22/27 | €0 |
| Financial fixed assets | 28 | €4k |
| Current assets | 29/58 | €155.73M |
| Amounts receivable within one year | 40/41 | €155.73M |
| Cash & bank | 54/58 | €4k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €156.13M |
| Equity | 10/15 | €53.38M |
| Contributions / capital | 10/11 | €10.94M |
| Reserves | 13 | €396k |
| Accumulated profits (losses) | 14 | €42.05M |
| Amounts payable | 17/49 | €102.75M |
| Amounts payable within one year | 42/48 | €102.75M |
| Trade debts payable within one year | 44 | €48.19M |
| Income statement | ||
| Turnover | 70 | €567.48M |
| Operating result | 9901 | €19.86M |
| Financial income | 75 | €1.18M |
| Financial charges | 65 | €99k |
| Result before taxes | 9903 | €20.94M |
| Income taxes | 67/77 | €5.44M |
| Net result for the period | 9904 | €15.50M |
| Result to be appropriated | 9905 | €15.63M |
-
Current01-12-2024 → present
-
Current02-05-2023 → present
-
Current01-06-2021 → present
Historic, not recently confirmed (7)
-
Not recently confirmedlast confirmed in an act from 2011
-
Not recently confirmedlast confirmed in an act from 2011
-
Not recently confirmedlast confirmed in an act from 2007
-
Not recently confirmedlast confirmed in an act from 2007
-
Not recently confirmedlast confirmed in an act from 2007
-
Not recently confirmedlast confirmed in an act from 2006
2 events
- 26-07-2006 Mandate renewed· Director
- 15-11-2004 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2005
Former directors (23)
-
Former01-06-2021 → 01-12-2024
2 events
- 01-12-2024 Resigned· Director
- 01-06-2021 Appointed· Director
-
Former01-03-2019 → 02-05-2023
2 events
- 02-05-2023 Resigned· Director
- 01-03-2019 Appointed· Manager
-
Former07-10-2019 → 01-06-2021
2 events
- 01-06-2021 Resigned· Director
- 07-10-2019 Appointed· Manager
-
Former01-05-2020 → 01-06-2021
2 events
- 01-06-2021 Resigned· Director
- 01-05-2020 Appointed· Director
-
Former01-09-2017 → 01-05-2020
2 events
- 01-05-2020 Resigned· Director
- 01-09-2017 Appointed· Manager
-
Former01-05-2011 → 07-10-2019
2 events
- 07-10-2019 Resigned· Manager
- 01-05-2011 Appointed· Niet statutair zaakvoerder
-
Former15-09-2016 → 01-03-2019
2 events
- 01-03-2019 Resigned· Manager
- 15-09-2016 Appointed· Manager
-
Former- → 01-09-2017
-
Former01-04-2013 → 15-09-2016
2 events
- 15-09-2016 Resigned· Manager
- 01-04-2013 Appointed· Manager
-
Former01-09-2011 → 30-11-2012
2 events
- 30-11-2012 Resigned· Manager
- 01-09-2011 Appointed· Manager
-
Former- → 11-11-2011
-
Former04-11-2009 → 01-09-2011
4 events
- 01-09-2011 Resigned· Manager
- 01-05-2011 Appointed· Niet statutair zaakvoerder
- 04-11-2009 Appointed· President
- 04-11-2009 Appointed· Directeur generaal
-
Former26-07-2006 → 01-05-2011
2 events
- 01-05-2011 Resigned· Director
- 26-07-2006 Appointed· Director
-
Former15-05-2008 → 01-05-2011
2 events
- 01-05-2011 Resigned· Director
- 15-05-2008 Appointed· Director
-
Former20-09-2004 → 04-11-2009
3 events
- 04-11-2009 Resigned· Directeur generaal
- 04-11-2009 Resigned· President
- 20-09-2004 Appointed· Directeur generaal
-
Former19-05-2008 → 02-07-2009
2 events
- 02-07-2009 Resigned· Director
- 19-05-2008 Appointed· Director
-
Former- → 30-05-2008
-
Former15-11-2004 → 15-05-2008
3 events
- 15-05-2008 Resigned· Director
- 26-07-2006 Mandate renewed· Director
- 15-11-2004 Appointed· Director
-
Former17-12-2003 → 15-11-2004
3 events
- 15-11-2004 Resigned· Director
- 20-09-2004 Resigned· Afgevaardigde bestuurder
- 17-12-2003 Appointed· Director
-
Former17-12-2003 → 15-11-2004
2 events
- 15-11-2004 Resigned· Director
- 17-12-2003 Appointed· Director
-
Former08-04-2004 → 15-11-2004
3 events
- 15-11-2004 Resigned· Director
- 08-04-2004 Appointed· Director
- 17-12-2003 Resigned· Director
-
Former- → 08-04-2004
-
Former- → 17-12-2003
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 23-10-1969 |
| Status | Active |
| Postal code | 1170 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21652E0905/00H000 | Brussels | 8.3 ha | 1 · 1.3 ha | 51.0 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
24-09-2025 1 director appointed, 1 resigning
- Arnaud Gain, Commissaris
- Didier Delanoye, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Arnaud Gain",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}22-07-2025 Board meeting · Statute amendment · General meeting · Officer appointment
- Publication: 22/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 11/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 23/04/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Statute amendment: wijziging delegatiereglement dagelijks bestuur · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 11/06/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Almirall N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Novo Nordisk Pharma N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Takeda Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Amgen N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · MSD Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Roche N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · UCB Pharma N.V.
- Officer resignation: role: bestuurder, end_date: 2025-06-11 · Vertex Pharmaceuticals (Netherlands) BV
- Permanent representative: start_date: 16/05/2025 · Paul Lacante
- Permanent representative · Gregory Paton
- Permanent representative · Axel De Muyt
- Permanent representative · Bruno Rabilier
Technical details
{
"facts": [
{
"date": "2025-07-22",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad -22/07/2025 - Annexes du Moniteur belge",
"value": "22/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-07-11",
"type": "filing",
"quote": "neergelegd/ontvangen op 114 JULI 2025",
"value": "11/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-04-23",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 23 APRIL 2025",
"value": "23/04/2025",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Onderwerp akte: Benoeming bestuurders - wijziging delegatiereglement dagelijks bestuur",
"value": "wijziging delegatiereglement dagelijks bestuur",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "general_meeting",
"quote": "GEWONE ALGEMENE VERGADERING VAN 11 JUNI 2025",
"value": "11/06/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Almirall N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Novo Nordisk Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Takeda Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. Amgen N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. MSD Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Roche N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e7",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e8",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Vertex Pharmaceuticals (Netherlands) BV",
"value": {
"role": "bestuurder",
"end_date": "2025-06-11"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "bestuurder",
"reason": "ontslag",
"end_date": "11/06/2025"
}
},
{
"date": "2025-05-16",
"type": "permanent_representative",
"quote": "Bristol-Myers Squibb Belgium N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 16/05/2025 de heer Paul Lacante",
"value": {
"start_date": "16/05/2025"
},
"object": "e10",
"subject": "e11"
},
{
"type": "permanent_representative",
"quote": "Almirall N.V. ... heeft als vaste vertegenwoordiger de heer Gregory Paton",
"value": {},
"object": "e2",
"subject": "e13"
},
{
"type": "permanent_representative",
"quote": "Novo Nordisk Pharma N.V. ... heeft als vaste vertegenwoordiger de heer Axel De Muyt",
"value": {},
"object": "e3",
"subject": "e14"
},
{
"type": "permanent_representative",
"quote": "Takeda Belgium N.V. ... heeft als vaste vertegenwoordiger de heer Bruno Rabilier",
"value": {},
"object": "e4",
"subject": "e15"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9714,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Kantersteen 47, 1000 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0403.090.131",
"kind": "company",
"name": "Almirall N.V.",
"attrs": {
"seat": "Lenneke Marelaan 4, 1932 Sint-Stevens-Woluwe"
}
},
{
"id": "e3",
"kbo": "0414.695.586",
"kind": "company",
"name": "Novo Nordisk Pharma N.V.",
"attrs": {
"seat": "Alfons Gossetlaan 32E/202, 1702 Groot-Bijgaarden"
}
},
{
"id": "e4",
"kbo": "0403.054.202",
"kind": "company",
"name": "Takeda Belgium N.V.",
"attrs": {
"seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
}
},
{
"id": "e5",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen N.V.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e6",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Vorstlaan 25, 1170 Watermaal-Bosvoorde"
}
},
{
"id": "e7",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e8",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e9",
"kbo": "0666.408.905",
"kind": "company",
"name": "Vertex Pharmaceuticals (Netherlands) BV",
"attrs": {
"seat": "Leidsevaart 20, NL - 2013 HA Haarlem"
}
},
{
"id": "e10",
"kbo": "0403.075.184",
"kind": "company",
"name": "Bristol-Myers Squibb Belgium N.V.",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Paul Lacante",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Sally McNab",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Gregory Paton",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Axel De Muyt",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Bruno Rabilier",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "company",
"name": "Facing BV",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}28-11-2024 1 director appointed, 1 resigning
- Ciar Harbord, Bestuurder
- Rietja Hart, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rietja Hart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ciar Harbord",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}08-07-2024 Didier Delanoye appointed as statutory auditor
- Didier Delanoye, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}21-06-2024 Permanent representative
- Publication: 21/06/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 13/06/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Permanent representative: start_date: 02/05/2023 · Katrien De Vos
- Permanent representative: end_date: 02/05/2023 · Brecht Vanneste
Technical details
{
"facts": [
{
"date": "2024-06-21",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 21/06/2024",
"value": "21/06/2024",
"object": null,
"subject": "e1"
},
{
"date": "2024-06-13",
"type": "filing",
"quote": "neergelegd/ontvangen op 13 JUNI 2024",
"value": "13/06/2024",
"object": null,
"subject": "e1"
},
{
"date": "2023-05-02",
"type": "permanent_representative",
"quote": "MSD Belgium B.V. (BE 0406.820.770) heeft als nieuwe vaste vertegenwoordiger vanaf 02/05/2023 mevrouw Katrien De Vos",
"value": {
"start_date": "02/05/2023"
},
"object": "e2",
"subject": "e3"
},
{
"type": "permanent_representative",
"quote": "in opvolging van de heer Brecht Vanneste",
"value": {
"revoked": true,
"end_date": "02/05/2023"
},
"object": "e2",
"status": "revoked",
"subject": "e4"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 926,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium B.V.",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Katrien De Vos",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Brecht Vanneste",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}21-06-2024 Act object · Permanent representative
- Publication: 21/06/2024
- Filing: 13/06/2024
- Act object: Nouveau représentant permanent d'un administrateur
- Permanent representative: replaces: e3, start_date: 02/05/2023 · Katrien De Vos
Technical details
{
"facts": [
{
"date": "2024-06-21",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 21/06/2024",
"value": "21/06/2024",
"object": null,
"subject": null
},
{
"date": "2024-06-13",
"type": "filing",
"quote": "neergelegd/ontvangen o\u0440 13 JUNI 2024",
"value": "13/06/2024",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Nouveau repr\u00E9sentant permanent d\u0027un adm\u00EDnistrateur",
"value": "Nouveau repr\u00E9sentant permanent d\u0027un administrateur",
"object": null,
"subject": null
},
{
"date": "2023-05-02",
"type": "permanent_representative",
"quote": "MSD Belgium SRL (BE 0406.820.770) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 02/05/2023 Madame Katrien De Vos, succ\u00E9dant \u00E0 Monsieur Brecht Vanneste.",
"value": {
"replaces": "e3",
"start_date": "02/05/2023"
},
"object": "e1",
"subject": "e2"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 905,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium SRL",
"attrs": {
"legal_form": "SRL"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Katrien De Vos",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Brecht Vanneste",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}29-06-2023 1 director appointed, 1 resigning
- Katrien De Vos, Bestuurder
- Brecht Vanneste, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Brecht Vanneste",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Katrien De Vos",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}17-04-2023 Registered office moved from Sint-Lambrechts-Woluwe to Watermaal-Bosvoorde
- Lynxbinnenhof 5, 1200 Sint-Lambrechts-Woluwe (Brussel) → Vorstlaan 25, 1170 Watermaal-Bosvoorde (Brussel)
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Vorstlaan 25, 1170 Watermaal-Bosvoorde (Brussel)",
"city": "Watermaal-Bosvoorde",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Vorstlaan",
"country": "BE",
"postcode": "1170",
"box_number": null,
"street_number": "25",
"locality_suffix": "(Brussel)"
},
"old_address": {
"raw": "Lynxbinnenhof 5, 1200 Sint-Lambrechts-Woluwe (Brussel)",
"city": "Sint-Lambrechts-Woluwe",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Lynxbinnenhof",
"country": "BE",
"postcode": "1200",
"box_number": null,
"street_number": "5",
"locality_suffix": "(Brussel)"
},
"effective_date": "2023-05-02",
"evidence_quote": "De bestuurders besluiter om de zetel van de Vennootschap te verplaatsen naar Vorstlaan 25, 1170 Watermaal-Bosvoorde (Brussel), met ingang vanaf 2 mei 2023.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "act_body",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Richard Liu",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-17",
"filing_date": "2023-04-06",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enige_bestuurder",
"date": "2023-03-30",
"unanimous": true
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Richard Liu",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [
"Uittreksel uit de eenparige schriftelijke besluiten van de bestuurders dd. 30 maart 2023",
"Bijzondere volmacht aan J\u00E9r\u00F4me Vermeylen, Richard Liu, Evrard de Lhoneux, Jef Sprengers en enige andere advocaat van ALTIUS CVBA"
]
}09-11-2022 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}03-08-2021 PwC Bedrijfsrevisoren appointed as statutory auditor
- PwC Bedrijfsrevisoren, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}11-06-2021 2 directors appointed, 2 resigning
- Rietja Hart, Bestuurder
- Joris Swennen, Bestuurder
- Anne Bitzer, Bestuurder
- Emmanuel Thiéry, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anne Bitzer",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Thi\u00E9ry",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rietja Hart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Joris Swennen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}18-01-2021 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Eric SPRUYT",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2021-01-18",
"filing_date": "2021-01-11",
"act_kind_objet": "VASTSTELLING VAN DE DEFINITIEVE WAARDE VAN HE\u0422"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2020-12-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "demerger_partial",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0406.820.770",
"name": "MSD Belgium",
"role": "demerged",
"address": "Lynx Binnenhof 5, 1200 Brissem",
"is_foreign": false,
"legal_form": "besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "Organon Belgium BV",
"role": "recipient",
"address": null,
"is_foreign": false,
"legal_form": "besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"5:121",
"5:133"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2020-10-31",
"exchange_ratio_text": "5.338.747 nieuwe aandelen van elk 1 euro",
"new_shares_issued_n": 5338747,
"real_estate_included": false,
"patrimony_description": "De overgedragen patrimoine bestaat uit de activa en passiva van de Organon Business, inclusief contracten, rechtsverhoudingen en werknemers, zoals omschreven in het partiele splitsingsvoorstel. De waarde van de overdracht is vastgesteld op basis van de balans per 31 oktober 2020.",
"equity_transferred_eur": 5371310.79,
"accounting_effective_date": "2020-11-01"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium",
"legal_form": "besloten vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Daisy Dekegel",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van MSD Belgium BV besliste de definitieve waarde van de overgedragen Organon Business-activa en -passiva vast te stellen op basis van de balans per 31 oktober 2020. De waarde bedroeg EUR 5.371.310,79, wat een stijging van EUR 32.563,21 ten opzichte van de oorspronkelijke waardering per 31 december 2019 was. De vergadering besloot de vermindering van het eigen vermogen van MSD Belgium BV aan te passen naar dit bedrag en de overdracht van de activa en passiva naar Organon Belgium BV te bevestigen. De tegenprestatie bestond uit 5.338.747 nieuwe aandelen van O",
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"volmacht"
],
"detected_real_type": "demerger_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}20-11-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
},
"legal_form_change": {
"new": "besloten vennootschap",
"old": "besloten vennootschap",
"changed": false
}
}23-09-2020 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Jonathan De Landsheere",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2020-09-23",
"filing_date": "2020-09-16",
"act_kind_objet": "Neerlegging en bekendmaking van een voorstel tot parti\u00EBle splitsing"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2020-09-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "demerger_partial",
"report_waiver": {
"summary": "De rapportplichten overeenkomstig artikelen 5:121 en 5:133 van het Wetboek van Vennootschappen en Verenigingen worden geweigerd voor de inbreng in natura.",
"articles": [
"5:121",
"5:133"
]
},
"restructuring": {
"parties": [
{
"kbo": "0406.820.770",
"name": "MSD Belgium BV",
"role": "demerged",
"address": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe",
"is_foreign": false,
"legal_form": "Besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0741.785.526",
"name": "Organon Belgium BV",
"role": "recipient",
"address": "Lynx Binnenhof 5, 1200 Brussel",
"is_foreign": false,
"legal_form": "Besloten vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 0.2064301216197447,
"legal_articles": [
"12:8",
"12:59",
"12:13"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2019-12-31",
"exchange_ratio_text": "0,2064301216197447 aandelen per bestaand aandeel",
"new_shares_issued_n": 5338747,
"real_estate_included": false,
"patrimony_description": "Een deel van het vermogen van MSD Belgium BV, met name de activiteiten van ontwikkeling, commercialisering, distributie en verkoop van de producten zoals opgenomen in Bijlage 1 (de \u0027Producten\u0027), wordt overgedragen aan Organon Belgium BV. Dit omvat de contracten, rechtsverhoudingen en werknemers die daarmee verband houden.",
"equity_transferred_eur": null,
"accounting_effective_date": "2020-11-01"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium",
"legal_form": "Besloten vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "ALTIUS CVBA",
"person_name": null,
"org_rep_person_name": "J\u00E9r\u00F4me Vermeylen"
},
"summary_narrative": "De bestuurders van MSD Belgium BV en Organon Belgium BV hebben een voorstel tot partiele splitsing opgesteld overeenkomstig artikel 12:59 van het Wetboek van Vennootschappen en Verenigingen. Het voorstel voorziet in de overdracht van een deel van het vermogen van MSD Belgium BV, met name de Organon Business, naar Organon Belgium BV, zonder dat MSD Belgium BV wordt ontbonden. De overdracht zal juridisch en boekhoudkundig vanaf 1 november 2020 plaatsvinden. De aandeelhouders van MSD Belgium BV zullen aandelen van Organon Belgium BV ontvangen in ruil voor hun aandelen, tegen een ratio van 0,20643",
"co_filed_documents": [
"Voorstel tot een met splitsing gelijkgestelde verrichting opgesteld door de bestuursorganen van MSD Belgium BV (de overdragende vennootschap) en Organon Belgium BV (de overnemende vennootschap) op 15 september 2020",
"Lijst van producten die moeten worden overgedragen aan de Organon Business",
"Lijst van over te dragen activa en passiva",
"Lijst van de over te dragen werknemers",
"Balans van de Organon Business per 31 december 2019",
"Balans van de Overnemende Vennootschap per 20 januari 2020"
],
"detected_real_type": "demerger_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}26-05-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
},
"legal_form_change": {
"new": "",
"old": "besloten vennootschap",
"changed": false
}
}24-10-2019 1 director appointed, 1 resigning
- Anne Bitzer, Zaakvoerder
- Eric Montariol, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Eric Montariol",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Anne Bitzer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 09/07/2019
- Filing: 28/06/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · MSD Belgium N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Roche N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Chiesi N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · UCB Pharma N.V.
- Board meeting: 24/04/2019
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Officer resignation: date: 2019-04-24, role: ondervoorzitter van de Raad van Bestuur · MSD Belgium N.V.
- Permanent representative · Clarisse Lhoste
- Officer appointment: role: CEO belast met het dagelijks bestuur · Catherine Rutten
Technical details
{
"facts": [
{
"date": "2019-07-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2019",
"value": "09/07/2019",
"object": null,
"subject": null
},
{
"date": "2019-06-28",
"type": "filing",
"quote": "vangen op 28 JUNI 2019 ter griffie van de Nederlandstalige ondernemingsrechtbank Brusss",
"value": "28/06/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 27 MAART 2019",
"value": "27/03/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. MSD Belgium N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. Roche N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e2",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Chiesi N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e3",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"date": "2019-03-27",
"role": "Raad van Bestuur"
},
"object": null,
"subject": "e4",
"_value_raw": {
"date": "27/03/2019",
"role": "Raad van Bestuur"
}
},
{
"date": "2019-04-24",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 APRIL 2019",
"value": "24/04/2019",
"object": null,
"subject": null
},
{
"date": "2019-04-24",
"type": "officer_appointment",
"quote": "Op de Raad van Bestuur van 24 april 2019 werd Celgene, vertegenwoordigd door Michel Collard, verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
"value": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "2019-04-24"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "24/04/2019"
}
},
{
"type": "permanent_representative",
"quote": "Celgene, vertegenwoordigd door Michel Collard",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"date": "2019-04-24",
"type": "officer_resignation",
"quote": "in opvolging van MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
"value": {
"date": "2019-04-24",
"role": "ondervoorzitter van de Raad van Bestuur"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "24/04/2019",
"role": "ondervoorzitter van de Raad van Bestuur"
}
},
{
"type": "permanent_representative",
"quote": "MSD Belgium, vertegenwoordigd door Clarisse Lhoste",
"value": null,
"object": "e1",
"subject": "e7"
},
{
"type": "officer_appointment",
"quote": "Catherine Rutten CEO belast met het dagelijks bestuur",
"value": {
"role": "CEO belast met het dagelijks bestuur"
},
"object": null,
"subject": "e8"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1672,
"truncated": false
},
"entities": [
{
"id": "e0",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
"legal_form": "Vereniging zonder winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi N.V.",
"attrs": {
"seat": "Telecomlaan 9, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "Celgene",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Michel Collard",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 2019
- Filing: 28/05/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · MSD Belgium S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Roche S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Chiesi S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · UCB Belgium S.A.
- Board meeting: 24/04/2019
- Officer appointment: role: Vice-Président du Conseil d'administration, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Permanent representative · Clarisse Lhoste
Technical details
{
"facts": [
{
"date": "2019-07-09",
"type": "publication",
"quote": "2019 - Annexes du Moniteur belge",
"value": "2019",
"object": null,
"subject": null
},
{
"date": "2019-05-28",
"type": "filing",
"quote": "neergelegd/ontvangen op 28 JUMM 2019",
"value": "28/05/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 27 MARS 2019",
"value": "27/03/2019",
"object": null,
"subject": null
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e1",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. Roche S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e2",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. Chiesi S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e3",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-03-27",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 4. UCB Belgium S.A.",
"value": {
"date": "2019-03-27",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e4",
"_value_raw": {
"date": "27/03/2019",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2019-04-24",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 AVRIL 2019",
"value": "24/04/2019",
"object": null,
"subject": null
},
{
"date": "2019-04-24",
"type": "officer_appointment",
"quote": "Celgene ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"start_date": "2019-04-24"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"start_date": "24/04/2019"
}
},
{
"type": "permanent_representative",
"quote": "Celgene, repr\u00E9sent\u00E9e par Michel Collard",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"type": "permanent_representative",
"quote": "MSD Belgium, repr\u00E9sent\u00E9e par Clarisse Lhoste",
"value": null,
"object": "e1",
"subject": "e7"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"publication date None -\u003E edition 2019-07-09"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1695,
"truncated": false
},
"entities": [
{
"id": "e0",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "Telecomlaan 9, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "Celgene",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Michel Collard",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}20-03-2019 1 director appointed, 1 resigning
- Brecht Vanneste, Zaakvoerder
- Clarisse Jacob Lhoste, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Clarisse Jacob Lhoste",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Brecht Vanneste",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}23-01-2019 2 directors appointed, 2 resigning
- PWC Bedrijfsrevisoren BV CVBA, Commissaris
- Didier Delanoye, Commissaris
- PWC Bedrijfsrevisoren BV CVBA, Commissaris
- Didier Delanoye, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PWC Bedrijfsrevisoren BV CVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PWC Bedrijfsrevisoren BV CVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}11-10-2017 1 director appointed, 1 resigning
- Tine Van den Haute, Zaakvoerder
- Chris Foreman, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Chris Foreman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Tine Van den Haute",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}22-08-2017 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD Belgium"
}
}14-06-2017 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Esther Goldschmidt",
"firm_city": null,
"firm_name": null,
"office_city": "Brussel",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2017-06-14",
"filing_date": "2017-06-02",
"act_kind_objet": "Neerlegging fusievoorstel"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2017-06-02",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0406.820.770",
"name": "MSD BELGIUM",
"role": "acquiring",
"address": "Lynx Binnenhof 5, 1200 Sint-Lambrechts-Woluwe",
"is_foreign": false,
"legal_form": "BVBA",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0402.506.646",
"name": "MSD VACCINES BELGIUM",
"role": "absorbed",
"address": "Leonardo Da Vincilaan 19, 1831 Diegem",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Het volledige vermogen van MSD Vaccines Belgium NV, inclusief actief, passief, rechten en verplichtingen, wordt overgenomen door MSD Belgium BVBA.",
"equity_transferred_eur": null,
"accounting_effective_date": "2017-01-01"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM",
"legal_form": "BVBA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Esther Goldschmidt",
"org_rep_person_name": null
},
"summary_narrative": "Op 2 juni 2017 werd een voorstel tot fusie door overneming gepubliceerd tussen MSD Belgium BVBA (overnemende vennootschap) en MSD Vaccines Belgium NV (over te nemen vennootschap). De fusie is van toepassing op artikel 693 en volgende van het Wetboek van Vennootschappen en is een vereenvoudigde fusie, aangezien MSD Belgium al alle aandelen van MSD Vaccines bezit. De fusie zal boekhoudkundig gelden vanaf 1 januari 2017.",
"co_filed_documents": [
"fusievoorstel van 2 juni 2017"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}24-10-2016 1 director appointed, 1 resigning
- Clarisse Jacob Lhoste, Zaakvoerder
- Patricia Massetti, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Patricia Massetti",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Clarisse Jacob Lhoste",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}20-06-2016 Didier Delanoye appointed as vaste vertegenwoordiger van de commissaris
- Didier Delanoye, Vaste vertegenwoordiger van de commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "vaste vertegenwoordiger van de commissaris",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}11-05-2016 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 11/05/2016 · Association Générale de l'Industrie du Médicament
- Filing: 29/04/2016 · Association Générale de l'Industrie du Médicament
- General meeting: 18/03/2016 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Roche S.A.
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Chiesi S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · MSD Belgium S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · UCB Belgium S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · AstraZeneca S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · Baxter Belgium SPRL
- Officer resignation: date: 2016-03-18, role: administrateur · Bracco Imaging Europe B.V.
- Statute amendment: article: 14, description: Poids des votes, procuration et procédure de vote · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 16, description: Composition du Conseil d'administration · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 21, description: Mandats · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 27ter, description: Organes (groupe pharma.be animal health) · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 33, description: Conditions d'admission et durée de mandat exceptionnelle · Association Générale de l'Industrie du Médicament
Technical details
{
"facts": [
{
"date": "2016-05-11",
"type": "publication",
"quote": "Bijlagen bij het Belgisch. Staatshlad -11/05/2016-",
"value": "11/05/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-04-29",
"type": "filing",
"quote": "neergelegd/entvangen op 29 APR, 2016",
"value": "29/04/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 18 MARS 2016",
"value": "18/03/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 1. Roche S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 2. Chiesi S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. UCB Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 1. AstraZeneca S.A.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 2. Baxter Belgium SPRL",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 3. Bracco Imaging Europe B.V.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"type": "statute_amendment",
"quote": "article 14. Poids des votes, procuration et proc\u00E9dure de vote",
"value": {
"article": "14",
"description": "Poids des votes, procuration et proc\u00E9dure de vote"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 16. Composition",
"value": {
"article": "16",
"description": "Composition du Conseil d\u0027administration"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 21. Mandats",
"value": {
"article": "21",
"description": "Mandats"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Article 27ter. Organes",
"value": {
"article": "27ter",
"description": "Organes (groupe pharma.be animal health)"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 33.",
"value": {
"article": "33",
"description": "Conditions d\u0027admission et dur\u00E9e de mandat exceptionnelle"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 16790,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "avenue du Bourget 44, 1130 Haren (Bruxelles)"
}
},
{
"id": "e4",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e5",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e6",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Uccle"
}
},
{
"id": "e7",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium SPRL",
"attrs": {
"seat": "boulevard d\u0027Angleterre 2-4, 1420 Braine l\u0027Alleud"
}
},
{
"id": "e8",
"kbo": "0892.349.322",
"kind": "company",
"name": "Bracco Imaging Europe B.V.",
"attrs": {
"seat": "avenue Pasteur 6, 1300 Wavre"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {
"role": "CEO charg\u00E9 de la gestion journali\u00E8re"
}
}
]
}04-12-2015 4 directors appointed, 1 resigning
- Jérôme Vermeylen, Volmacht
- Esther Goldschmidt, Volmacht
- Alexandra Sansen, Volmacht
- Kirian Claeyé, Volmacht
- Alette Verbeek, Volmacht
Technical details
{
"events": [
{
"kind": "director_out",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Alette Verbeek",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "J\u00E9r\u00F4me Vermeylen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Esther Goldschmidt",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Alexandra Sansen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "volmacht",
"person": {
"rrn": null,
"name": "Kirian Claey\u00E9",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}22-07-2015 2 directors appointed
- PwC Bedrijfsrevisoren, Commissaris
- Jan De Laet, Vertegenwoordiger commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Jan De Laet",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0406.820.770",
"name_full": "MSD BELGIUM"
}
}09-12-2014 Board meeting · Power of attorney · Filing representative
- Publication: 09/12/2014 · MSD BELGIUM
- Filing: 28/11/2014 · MSD BELGIUM
- Board meeting: 06/11/2014 · MSD BELGIUM
- Power of attorney: scope: Toekenning van bijzondere volmachten aan personen met specifieke titels (Market Access Head, Medical Director, etc.) voor het ondertekenen van specifieke overeenkomsten (sprekers, adviesraden, arbeidsovereenkomsten, sponsoring, confidentialiteit, klinische testen). Vervanging van de regeling van 13 december 2012. · MSD BELGIUM
- Filing representative: scope: Vervulling van de formaliteiten voor de neerlegging en publicatie van het besluit tot toekenning van een volmacht · ALTIUS
Technical details
{
"facts": [
{
"date": "2014-12-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/12/2014",
"value": "09/12/2014",
"object": null,
"subject": "e1"
},
{
"date": "2014-11-28",
"type": "filing",
"quote": "neergelegd/entvangen op 28 NOV. 2014",
"value": "28/11/2014",
"object": null,
"subject": "e1"
},
{
"date": "2014-11-06",
"type": "board_meeting",
"quote": "Uittreksel uit de eenparige schriftelijke besluiten van de zaakvoerders genomen op 6 november 2014",
"value": "06/11/2014",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "De zaakvoerders besluiten om de personen die, van tijd tot tijd, binnen de Vennootschap de titels dragen die hierna vermeld worden (de \u0022Gevolmachtigden\u0022), met onmiddellijke ingang te benoemen als rechtsgeldige gevolmachtigden van de Vennootschap... De zaakvoerders besluiten om de volgende bijzondere volmachten te verlenen...",
"value": {
"scope": "Toekenning van bijzondere volmachten aan personen met specifieke titels (Market Access Head, Medical Director, etc.) voor het ondertekenen van specifieke overeenkomsten (sprekers, adviesraden, arbeidsovereenkomsten, sponsoring, confidentialiteit, klinische testen). Vervanging van de regeling van 13 december 2012."
},
"object": null,
"subject": "e1"
},
{
"type": "filing_representative",
"quote": "De zaakvoerders besluiten een bijzondere volmacht te verlenen aan J\u00E9r\u00F4me Vermeylen, Kurt Grillet, Alexandra Sansen en Esther Goldschmidt, en enige andere advocaat van het advocatenkantoor ALTIUS... bevoegd om... de Vennootschap te vertegenwoordigen met het oog op de vervulling van de formaliteiten voor de neerlegging en publicatie vna het bovenstaande besluit",
"value": {
"scope": "Vervulling van de formaliteiten voor de neerlegging en publicatie van het besluit tot toekenning van een volmacht"
},
"object": "e1",
"subject": "e6"
}
],
"act_meta": {
"outcome": "review",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 4554,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD BELGIUM",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Brussel, Belgi\u00EB",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "J\u00E9r\u00F4me Vermeylen",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Kurt Grillet",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Alexandra Sansen",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Esther Goldschmidt",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "org",
"name": "ALTIUS",
"attrs": {
"address": "Havenlaan 86 C B.414, 1000 Brussel"
}
}
]
}03-06-2013 Act object · General meeting · Officer appointment · Filing representative
- Act object: Benoeming van een zaakvoerder · MSD BELGIUM
- Publication: 03/06/2013 · MSD BELGIUM
- Filing: 23/05/2013 · MSD BELGIUM
- General meeting: 27/03/2013 · MSD BELGIUM
- Officer appointment: role: zaakvoerder, term: onbepaalde duur, start_date: 2013-04-01 · Patricia Massetti
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Altius CVBA
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Jérôme Vermeylen
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Kathelijne Beckers
- Filing representative: bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen · Esther Goldschmidt
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte: Benoeming van een zaakvoerder",
"value": "Benoeming van een zaakvoerder",
"object": null,
"subject": "e1"
},
{
"date": "2013-06-03",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 03/06/2013",
"value": "03/06/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-05-23",
"type": "filing",
"quote": "23 M 2013",
"value": "23/05/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-03-27",
"type": "general_meeting",
"quote": "Uittreksel uit de eenparige schriftelijke besluiten van de vennoten van 27 maart 2013",
"value": "27/03/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-04-01",
"type": "officer_appointment",
"quote": "De vennoten besluiten mevrouw Patricia Massetti ... met ingang per 1 april 2013 en voor onbepaalde duur als zaakvoerder van de Vennootschap te benoemen.",
"value": {
"role": "zaakvoerder",
"term": "onbepaalde duur",
"start_date": "2013-04-01"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "zaakvoerder",
"term": "onbepaalde duur",
"start_date": "01/04/2013"
}
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e3"
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e4"
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e5"
},
{
"type": "filing_representative",
"quote": "De vennoten besluiten een bijzondere volmacht, met mogelijkheid van indeplaatsstelling, toe te kennen aan J\u00E9r\u00F4me Vermeylen, Kathelijne Beckers en Esther Goldschmidt en aan iedere andere advocaat van het kantoor Altius CVBA ... bevoegd om afzonderlijk te handelen en om de Vennootschap te vertegenwoordigen voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"value": "bijzondere volmacht, met mogelijkheid van indeplaatsstelling ... voor het vervullen van de wettelijk vereiste neerleggings- en publicatieverplichtingen",
"object": "e1",
"subject": "e6"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1823,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD BELGIUM",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Brussel, Belgi\u00EB",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Patricia Massetti",
"attrs": {
"address": "B-1200 Brussel, Lynx Binnenhof 5"
}
},
{
"id": "e3",
"kbo": null,
"kind": "org",
"name": "Altius CVBA",
"attrs": {
"address": "Havenlaan 86C B.414, B-1000 Brussel"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "J\u00E9r\u00F4me Vermeylen",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Kathelijne Beckers",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Esther Goldschmidt",
"attrs": {}
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | MSD BELGIUM |